John L. Villano, MD, PhD

Quick facts

Phase 3 pipeline

• Immune checkpoint inhibitor · Oncology
  Immune checkpoint inhibitors block inhibitory signals on T cells, allowing the immune system to recognize and attack cancer cells.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• John L. Villano, MD, PhD portfolio CI brief
• John L. Villano, MD, PhD pipeline updates RSS